Why is Eyebright Medical Technology (Beijing) Co., Ltd. ?
1
Negative results in Sep 25
- INTEREST(9M) At CNY 16.99 MM has Grown at 13.49%
- ROCE(HY) Lowest at 14.04%
- INTEREST COVERAGE RATIO(Q) Lowest at 1,571.7
2
With ROE of 14.14%, it has a expensive valuation with a 4.99 Price to Book Value
- Over the past year, while the stock has generated a return of -40.29%, its profits have risen by 20.2% ; the PEG ratio of the company is 1.8
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -40.29% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Eyebright Medical Technology (Beijing) Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Eyebright Medical Technology (Beijing) Co., Ltd.
-43.02%
-0.69
35.22%
China Shanghai Composite
23.91%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
35.69%
EBIT Growth (5y)
19.17%
EBIT to Interest (avg)
83.12
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.43
Tax Ratio
9.26%
Dividend Payout Ratio
22.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.21%
ROE (avg)
12.24%
Valuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
2.66
EV to EBIT
28.30
EV to EBITDA
19.12
EV to Capital Employed
2.41
EV to Sales
5.35
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
8.51%
ROE (Latest)
8.28%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Bearish
Technical Movement
2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -1.61% (YoY
-14What is not working for the Company
NET PROFIT(HY)
At CNY 67.49 MM has Grown at -58.54%
ROCE(HY)
Lowest at 9.97%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.78 times
DEBT-EQUITY RATIO
(HY)
Highest at 18.87 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.77 times
Here's what is working for Eyebright Medical Technology (Beijing) Co., Ltd.
Raw Material Cost
Fallen by -1.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Eyebright Medical Technology (Beijing) Co., Ltd.
Net Profit
At CNY 67.49 MM has Grown at -58.54%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 2.78 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Debt-Equity Ratio
Highest at 18.87 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 1.77 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






